ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

Upton Heads NIH Effort To Define Prevention

April 21, 1978

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999